We describe a premature infant with early cystic lung lesions and sepsis due to prenatally acquired Capnocytophaga infection. Early cystic lesions have not been described previously as a characteristic of this infection.
Introduction

First described as a human pathogen in 1979, infections with
Capnocytophaga species can be categorized into four clinical groupings: bite wound infections and sepsis from the animal species C. canimorsus and C. cynodegmi (>90% of all reported infections) and three categories of disease owing to human Capnocytophaga species -localized periodontal infections, sporadic invasive infections (sepsis, endocarditis, osteomyelitis, etc.) and neonatal infections. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Sporadic invasive disease occurs primarily in immunocompromised persons, with neutropenia or asplenia. 15 Neonatal disease is a rare but significant cause of bacteremia in the perinatal period. Delayed diagnosis may contribute to poor outcomes.
This following case presents a premature infant with early cystic lung lesions and sepsis due to prenatally acquired Capnocytophaga infection. Early cystic lesions have not been described previously as a characteristic of this infection.
Case report
An afebrile and previously well 32-year-old woman, presented in labor with intact membranes at 28 weeks gestation. Prenatal history was unremarkable and routine fetal ultrasound had been normal. Labor progressed quickly preventing administration of prenatal steroids. A male infant (1325 g.) was delivered vaginally with APGAR scores of 3 and 6 at 1 and 5 min respectively. The patient was intubated, surfactant administered and high-frequency oscillatory ventilation was begun.
Initial laboratory investigations revealed a peripheral white blood cell count of 4.1 Â 10 6 /l with a band count of 20% and a C-reactive protein (CRP) of 23 mg/l. Blood cultures were drawn and empiric intravenous ampicillin and cefotaxime were started. Thrombocytopenia and hemodynamic instability prevented lumbar puncture. No respiratory cultures were obtained before antibiotic therapy. Persistent metabolic acidosis, hypotension and oliguria developed -compatible with overwhelming sepsis. The initial chest X-ray was consistent with respiratory distress syndrome, but bilateral cystic lung lesions appeared by day 3 of life ( Figure 1 ).
On the 5th day of incubation, a gram-negative bacillus was isolated from the anaerobic blood culture bottle and, subsequently identified as Capnocytophaga sputigena (confirmed by DNA sequencing). The isolate was b-lactamase negative. The infant's condition improved and all cystic pulmonary lesions resolved following completion of a 14-day cefotaxime course. The infant appeared well at discharge on day 77. Follow-up at 18 months of age (corrected) revealed no respiratory sequelae but the presence of spastic cerebral palsy.
Discussion
Microbiology
Capnocytophaga are slender, fusiform, Gram-negative rods, originally classified as Fusobacteria, and named for their 'consumption' or requirement for CO 2 . Seven species are recognized in humans: C. gingivalis, C. sputigena, C. ochracea, C. granulosa, and C. haemolytica and two (C. cynodegmi and C. canimorsus) in both dogs and cats. 16 Human species colonize both oral and vaginal mucosa and cause localized, periodontal, disease, sporadic cases of invasive disease in children and adults, and neonatal infections. 14, 15, 17 Laboratory identification can be difficult: organisms are often pleomorphic, with fusiform bacilli mixed with swollen cells and coccal forms. Capnocytophaga are fastidious facultative anaerobes -requiring an atmosphere of 5 to 10% CO 2, a temperature of 35 to 371C, and rich media (i.e. sheep blood or chocolate agar) for their optimal, albeit slow growth. Animal species may be differentiated from human species by their positive catalase and oxidase reactions. Distinguishing between human species may require DNA sequencing. Capnocytophaga are typically susceptible to extended spectrum (third-generation) cephalosporins, carbapenems, quinolones, and (surprisingly) clindamycin. b-Lactamase production with resistance to penicillin, ampicillin and first-generation cephalosporins is reported, but these strains remain susceptible to b-lactam/ b-lactamase inhibitor combinations. Rare strains are resistant to quinolones and third generation cephalosporins. Capnocytophaga species are generally resistant to astreonam, aminoglycosides, trimethoprim and metronidazole. This resistance pattern can be problematic in scenarios such as neonatal infections where a b-lactam and aminoglycoside may be used as initial empiric therapy. Pathophysiology Chorioamnionitis or fetal sepsis may occur via ascending infection or hematogenous spread when membranes remain intact. Capnocytophaga chorioamnionitis with fetal death, preterm labor or neonatal disease is reported following oral sex with partners having poor dental hygiene. 1, 3, 7 The uterine environment, immunologically suppressed during pregnancy to prevent reaction to fetal antigens, may enable otherwise non-pathogenic organisms to cause infection. 18 Our case most likely represents an ascending infection, and subclinical chorioamnionitis, as suggested by the lack of maternal symptoms. Neonatal bacteremia in with resultant pulmonary cysts/abscesses is reminiscent of Lemierre's syndrome: whereby another fusiform gram-negative bacillus (Fusobacterium necrophorum) causes bacteremia and secondary pulmonary abscesses. In the postnatal period, mucous membrane exposure to canine saliva (via facial licking) has been associated with C. canimorsus meningitis in one newborn. 19 Review of perinatal literature Human Capnocytophaga species, while of low virulence, have potential to be invasive ( Table 1 ). The risk is greater in the infant than mother; of 15 neonatal cases reported, 8/15 women were asymptomatic or had minimal symptoms. Maternal signs and symptoms range from subclinical infection to preterm labor with overt sepsis and uterine tenderness. Of 15 infants reported, there was one stillbirth. In 14 liveborn infants, eight had positive cultures. The absence of a positive neonatal culture did not predict a lessened severity of illness in the neonate. Twelve infants had neonatal data available. Two were completely asymptomatic, five were significantly ill with birth depression and hypotension at delivery, one had disseminated intravascular coagulation (DIC) and one presented with hydrops.
Three infants presented with unusual chest X-ray findings unexplainable solely by respiratory distress syndrome (RDS): ranging from patchy infiltrate to the cystic lesions seen in our case. Our case was distinctive in the rapid evolution (72 h) from typical RDS 'ground glass' lung fields to multiple cystic lesions. This progression -faster than is seen with bronchopulmonary dysplasia -gave rise to alternative diagnoses such as congenital cystic adenomatoid malformation or pulmonary sequestration.
Conclusion
Maternal and neonatal disease owing to Capnocytophaga has a broad spectrum of presentation. Preterm delivery is clearly a risk factor, but premature rupture of membranes is not a pre-requisite. The organism is more virulent in neonates than their mothers, with maternal infection often being subclinical. Rapid laboratory identification of Capnocytophaga species is critical, but problematic owing to their fastidious growth requirements and pleomorphic morphology. This, combined with frequent production b-lactamase and variable aminoglycoside susceptibility -common empiric choices in neonates with suspected sepsis -creates a potentially disastrous clinical scenario. Clinicians should maintain an index of suspicion for this organism when managing premature infants with 'culture-negative' sepsis, when a fastidious Gram-negative rod is isolated from neonatal blood culture, or when early cystic pulmonary lesions accompany neonatal sepsis.
